$aTyr Pharma(LIFE.US)$ Management highlighted plans to launch the ATYR1923 PH3 trial in pulmonary sarcoidosis in 2022. The company will also present additional preclinical data from ATYR2810 at SITC 2021 tomorrow and plans to move ATYR2810 into clinical trials next year. Recent attention has focused on the ph3 trial design conducted after the company's meeting with the FDA.
$aTyr Pharma(LIFE.US)$ Following successful completion of PH2, aTyr plans to hold a meeting with FDA to discuss the PH3 study design as soon as possible, and data release is in the works. The company recently announced a collaboration with Ohio State University to develop a companion diagnosis as a predictive biomarker for granuloma formation to identify better responders to ATRY1923 in pulmonary sarcoidosis.
$aTyr Pharma(LIFE.US)$A dip at open to 11.30 would mean a run up to 12.60. Has to stay above 10.82 tho. May have enough support to only dip to 11.47 then run to 12.60.
13
9
1
举报
ItzMe17 :
@Tupack H Mcsnacks: thanks for the heads up . Curious to know the reason behind such a drop and flying high in 2 days. Can you educate me so I can put the money confidently
Mcsnacks H Tupack楼主ItzMe17:
Price is decreasing because of low volume and short shares being sold. Those short shares have to be replaced by Preferably being bought at a cheaper price. And they can’t wait very long to do it because they are being charged 700% interest on the loaned shares. And they know the only way now for it to decrease is by people selling their shares because the price is falling. Once there is more buying than selling and the price starts increasing then the shorts will start buying before their profit is gone. This causes investors to take notice when the price increases so much in premarket or after hours so they start buying. Then a squeeze starts.
Mcsnacks H Tupack楼主ItzMe17:
Basically hedge funds trying to make a quick buck and It has to be quick because it costs a lot of money by The day. So they make it Go down until they can turn a profit which is at about 23.00-26.00.
Mcsnacks H Tupack楼主ItzMe17:
The other stock is because it’s 85% owned. So everytime it gets to 100% it sells off. Then repeats near where it began at the 83-87% mark.
aTyr Pharma股票讨论区
🚀
Fcking genius alert is better than paid discords 🤑🤑🤑🚀🚀🚀 alerted bottoms 1.07
Load this shit up next month gonna be massive squeeze
Management highlighted plans to launch the ATYR1923 PH3 trial in pulmonary sarcoidosis in 2022. The company will also present additional preclinical data from ATYR2810 at SITC 2021 tomorrow and plans to move ATYR2810 into clinical trials next year. Recent attention has focused on the ph3 trial design conducted after the company's meeting with the FDA.
Hold or sell
I bought at 9.8 .last 2 weeks it is hovering around 9 .any chance of break even?
Following successful completion of PH2, aTyr plans to hold a meeting with FDA to discuss the PH3 study design as soon as possible, and data release is in the works. The company recently announced a collaboration with Ohio State University to develop a companion diagnosis as a predictive biomarker for granuloma formation to identify better responders to ATRY1923 in pulmonary sarcoidosis.
Stocks with no short shares available and high interest
暂无评论